137 related articles for article (PubMed ID: 28867717)
1. Effects of Tripterygium wilfordii Induction Therapy to IgA Nephropathy Patients with Heavy Proteinuria.
Wang Z; Yu C; Zhou LN; Chen X
Biol Pharm Bull; 2017 Nov; 40(11):1833-1838. PubMed ID: 28867717
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of Tripterygium wilfordii Hook F in the immunosuppressive treatment of IgA nephropathy.
Chen YZ; Gao Q; Zhao XZ; Chen XM; Zhang F; Chen J; Xu CG; Sun LL; Mei CL
Intern Med; 2010; 49(19):2049-55. PubMed ID: 20930429
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness and safety of KunXian capsule for the treatment of IgA nephropathy.
Le WB; Shi JS; Gong SW; Yang F
BMC Nephrol; 2022 May; 23(1):179. PubMed ID: 35538439
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the efficacy and safety of TWHF in diabetic nephropathy patients with overt proteinuria and normal eGFR.
Xiong C; Li L; Bo W; Chen H; XiaoWei L; Hongbao L; Peng Z
J Formos Med Assoc; 2020 Mar; 119(3):685-692. PubMed ID: 31801679
[TBL] [Abstract][Full Text] [Related]
5. Tripterygium wilfordii Hook F as Maintenance Treatment for Crohn's Disease.
Sun J; Shen X; Dong J; Wang H; Zuo L; Zhao J; Zhu W; Li Y; Gong J; Li J
Am J Med Sci; 2015 Nov; 350(5):345-51. PubMed ID: 26473333
[TBL] [Abstract][Full Text] [Related]
6. Mechanism for the therapeutic effect of
Zhao J; Liu H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 May; 47(5):573-582. PubMed ID: 35753727
[TBL] [Abstract][Full Text] [Related]
7. A meta-analysis of effects and safety of Tripterygium wilfordii polyglycoside in the treatment of IgA nephropathy.
Wang RX; Liao BQ; Chen W; Zhang YM; Tang XH; Xie FH
Eur Rev Med Pharmacol Sci; 2022 Dec; 26(23):8756-8770. PubMed ID: 36524494
[TBL] [Abstract][Full Text] [Related]
8. A PRISMA-compliant systematic review and network meta-analysis on the efficacy between different regimens based on Tripterygium wilfordii Hook F in patients with primary nephrotic syndrome.
Wang XB; Dai EL; Xue GZ; Ma RL
Medicine (Baltimore); 2018 Jul; 97(27):e11282. PubMed ID: 29979395
[TBL] [Abstract][Full Text] [Related]
9. The effects of
Cheng Y; Liu Y; Lin L; Li D; Peng L; Zheng K; Tao J; Li M
Ren Fail; 2024 Dec; 46(1):2295425. PubMed ID: 38178377
[TBL] [Abstract][Full Text] [Related]
10. Mycophenolate Mofetil Combined With Prednisone Versus Full-Dose Prednisone in IgA Nephropathy With Active Proliferative Lesions: A Randomized Controlled Trial.
Hou JH; Le WB; Chen N; Wang WM; Liu ZS; Liu D; Chen JH; Tian J; Fu P; Hu ZX; Zeng CH; Liang SS; Zhou ML; Zhang HT; Liu ZH
Am J Kidney Dis; 2017 Jun; 69(6):788-795. PubMed ID: 28215945
[TBL] [Abstract][Full Text] [Related]
11. [The effects and mechanism of Tripterygium wilfordii Hook F combination with irbesartan on urinary podocyte excretion in diabetic nephropathy patients].
Ma RX; Zhao N; Zhang W
Zhonghua Nei Ke Za Zhi; 2013 Jun; 52(6):469-73. PubMed ID: 24059992
[TBL] [Abstract][Full Text] [Related]
12. Low-dose of multi-glycoside of Tripterygium wilfordii Hook. f., a natural regulator of TGF-β1/Smad signaling activity improves adriamycin-induced glomerulosclerosis in vivo.
Wan YG; Che XY; Sun W; Huang YR; Meng XJ; Chen HL; Shi XM; Tu Y; Wu W; Liu YL
J Ethnopharmacol; 2014 Feb; 151(3):1079-1089. PubMed ID: 24362077
[TBL] [Abstract][Full Text] [Related]
13. Based on Network Pharmacology Tools to Investigate the Mechanism of
Xia M; Liu D; Liu H; Zhao J; Tang C; Chen G; Liu Y; Liu H
Front Med (Lausanne); 2021; 8():794962. PubMed ID: 34977095
[No Abstract] [Full Text] [Related]
14. Efficacy and safety of Tripterygium wilfordii Hook F for CKD in Mainland China: A systematic review and meta-analysis.
Wang D; Zhao XH; Cui Y; Zhang TT; Wang F; Hu YH
Phytother Res; 2018 Mar; 32(3):436-451. PubMed ID: 29193402
[TBL] [Abstract][Full Text] [Related]
15. Treatment of diabetic nephropathy with Tripterygium wilfordii Hook F extract: a prospective, randomized, controlled clinical trial.
Ge Y; Xie H; Li S; Jin B; Hou J; Zhang H; Shi M; Liu Z
J Transl Med; 2013 May; 11():134. PubMed ID: 23725518
[TBL] [Abstract][Full Text] [Related]
16. Comparison of oral steroids with tonsillectomy plus steroid pulse therapy in patients with IgA nephropathy.
Hoshino Y; Moriyama T; Uchida K; Tsuchiya K; Nitta K
Clin Exp Nephrol; 2017 Aug; 21(4):617-623. PubMed ID: 27549901
[TBL] [Abstract][Full Text] [Related]
17. Remission of proteinuria improves prognosis in IgA nephropathy.
Reich HN; Troyanov S; Scholey JW; Cattran DC;
J Am Soc Nephrol; 2007 Dec; 18(12):3177-83. PubMed ID: 17978307
[TBL] [Abstract][Full Text] [Related]
18. The Active Compounds and Therapeutic Target of
Liu P; Zhang J; Wang Y; Shen Z; Wang C; Chen DQ; Qiu X
Front Med (Lausanne); 2021; 8():747922. PubMed ID: 34621768
[No Abstract] [Full Text] [Related]
19. A phase I study of ethyl acetate extract of the chinese antirheumatic herb Tripterygium wilfordii hook F in rheumatoid arthritis.
Tao X; Cush JJ; Garret M; Lipsky PE
J Rheumatol; 2001 Oct; 28(10):2160-7. PubMed ID: 11669150
[TBL] [Abstract][Full Text] [Related]
20. Treatment of bullous pemphigoid in Chinese patients with Tripterygium wilfordii Hook F.
Ge XL; Li SZ; Jin X; Jin HZ; Zuo YG
Dermatol Ther; 2020 Jul; 33(4):e13721. PubMed ID: 32500934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
